(CIDRAP News) – Three University of Texas facilities have recently had laboratory accidents with dangerous pathogens, including the agents of anthrax, tularemia, and shigellosis, according to a statement yesterday from the Sunshine Project, a nonprofit group that monitors biodefense research safety.
(CIDRAP News) – Researchers from the University of Michigan recently reported promising results in animal tests of an inhaled anthrax vaccine, offering hope for a vaccine that would cause fewer side effects and be easier to store and administer than the licensed vaccine.
(CIDRAP News) – Two people from Danbury, Conn., were recently diagnosed with cutaneous anthrax infections, probably because of exposure to spores on untanned animal hides brought from Africa.
(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) yesterday released a lengthy list of safety violations it found in an investigation of a biodefense laboratory at Texas A&M University, where research on dangerous pathogens was suspended 2 months ago after problems came to light.
(CIDRAP News) – A graduate student working in a biosafety level 3 (BSL-3) laboratory at the University of Mississippi Medical Center (UMMC) was treated for possible anthrax exposure following a laboratory accident Aug 11—two days after a US House committee announced plans to hold hearings on biodefense lab safety.
(CIDRAP News) – This year's round of federal grants to states to help healthcare facilities prepare for public health emergencies totals $430 million, down from $450 million last year, the US Department of Health and Human Services (HHS) announced recently.
(CIDRAP News) VaxGen Inc., which lost an $877.5 million contract with the US government for a new anthrax vaccine in December, announced May 24 it was stopping development of the vaccine and said it hopes to license the product to another company.
(CIDRAP News) At first glance, the Web page looks like an overhead shot of a fantastic game board: a mapidentifiably Los Angelessprinkled with faceted roundels in a half-dozen colors.
(CIDRAP News) – The US Department of Health and Human Services (HHS) recently unveiled its plan for developing and buying medical countermeasures against a range of biological, chemical, and other threats, with new anthrax and smallpox vaccines among the near-term priorities.
(CIDRAP News) Faced with the reality that an effective vaccine is not likely to be available for at least the first several months of an influenza pandemic, some corporations are buying antiviral medications for their employeesboth to protect them and to improve the chances that the company could keep providing vital products and services through a pandemic.
